Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

KY Thong; Biju Jose; Andrew Blann; ML Cull; AP Mills; T Sathyapalan; C Walton; RE Ryder

doi:10.1016/j.diabres.2011.05.015

Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

KY Thong, Biju Jose, Andrew Blann, ML Cull, AP Mills, T Sathyapalan, C Walton, RE Ryder

Birmingham Medical School

Research output: Contribution to journal › Article

18 Citations (Scopus)

Abstract

It is uncertain what should be done with insulin dose if starting exenatide. In the ABCD nationwide exenatide audit, many patients with type 2 diabetes had worsened glycaemia when insulin was stopped. If starting exenatide, insulin should not be stopped but weaned off only if there is significant glycaemic response.

Original language	English
Pages (from-to)	e87-91
Journal	Diabetes Research and Clinical Practice
Volume	93
DOIs	https://doi.org/10.1016/j.diabres.2011.05.015
Publication status	Published - 1 Jan 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.diabres.2011.05.015

Cite this

@article{0de37d010d08498286c4ccff1b7c3e1b,

title = "Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit",

abstract = "It is uncertain what should be done with insulin dose if starting exenatide. In the ABCD nationwide exenatide audit, many patients with type 2 diabetes had worsened glycaemia when insulin was stopped. If starting exenatide, insulin should not be stopped but weaned off only if there is significant glycaemic response.",

author = "KY Thong and Biju Jose and Andrew Blann and ML Cull and AP Mills and T Sathyapalan and C Walton and RE Ryder",

year = "2011",

month = jan,

day = "1",

doi = "10.1016/j.diabres.2011.05.015",

language = "English",

volume = "93",

pages = "e87--91",

journal = "Diabetes Research and Clinical Practice",

publisher = "Elsevier",

}

TY - JOUR

T1 - Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

AU - Thong, KY

AU - Jose, Biju

AU - Blann, Andrew

AU - Cull, ML

AU - Mills, AP

AU - Sathyapalan, T

AU - Walton, C

AU - Ryder, RE

PY - 2011/1/1

Y1 - 2011/1/1

N2 - It is uncertain what should be done with insulin dose if starting exenatide. In the ABCD nationwide exenatide audit, many patients with type 2 diabetes had worsened glycaemia when insulin was stopped. If starting exenatide, insulin should not be stopped but weaned off only if there is significant glycaemic response.

AB - It is uncertain what should be done with insulin dose if starting exenatide. In the ABCD nationwide exenatide audit, many patients with type 2 diabetes had worsened glycaemia when insulin was stopped. If starting exenatide, insulin should not be stopped but weaned off only if there is significant glycaemic response.

U2 - 10.1016/j.diabres.2011.05.015

DO - 10.1016/j.diabres.2011.05.015

M3 - Article

C2 - 21636161

VL - 93

SP - e87-91

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

ER -

Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this